Prestige Consumer Healthcare Inc. (PBH)

Market Cap	3.70B
Revenue (ttm)	1.14B
Net Income (ttm)	214.61M
Shares Out	49.23M
EPS (ttm)	4.29
PE Ratio	17.81
Forward PE	16.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	377,374
Open	76.31
Previous Close	76.42
Day's Range	74.99 - 76.67
52-Week Range	64.94 - 90.04
Beta	0.43
Analysts	Buy
Price Target	94.00 (+25.23%)
Earnings Date	Aug 7, 2025

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Feb 10, 2005
• Employees: 600
• Stock Exchange: NYSE
• Ticker Symbol: PBH
• Website: https://www.prestigebrands.com

Financial Performance

In 2024, PBH's revenue was $1.14 billion, an increase of 1.10% compared to the previous year's $1.13 billion. Earnings were $214.61 million, an increase of 2.52%.

Analyst Summary

According to 5 analysts, the average rating for PBH stock is "Buy." The 12-month stock price target is $94.0, which is an increase of 25.23% from the latest price.

Price Target

$94.0

(25.23% upside)

Analyst Consensus: Buy